0001562180-23-002670.txt : 20230309 0001562180-23-002670.hdr.sgml : 20230309 20230309164214 ACCESSION NUMBER: 0001562180-23-002670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Green Eric Mark CENTRAL INDEX KEY: 0001336007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 23720316 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2023-03-07 false 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001336007 Green Eric Mark 530 HERMAN O. WEST DRIVE EXTON PA 19341 true true false false President & CEO Common Stock 2023-03-07 4 M false 50000.00 57.38 A 135705.0865 D Common Stock 2023-03-07 4 S false 3154.00 320.6002 D 85705.0865 D Common Stock 2023-03-07 4 S false 7685.00 321.6138 D 88859.0865 D Common Stock 2023-03-07 4 S false 26753.00 322.4874 D 96544.0865 D Common Stock 2023-03-07 4 S false 5277.00 323.3804 D 123297.0865 D Common Stock 2023-03-07 4 S false 1131.00 324.29 D 128574.0865 D Stock Option (Right to Buy) 57.38 2023-03-07 4 M false 50000.00 0.00 D 2025-04-24 Common Stock 50000.00 198132.00 D The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in 2025, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 9/14/2022. This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 9/14/2022. The Rule 10b5-1 trading plan, which was structured to include several sale periods, was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time. In total, 50,000 options were exercised with 44,000 shares sold and 6,000 shares held by the reporting person. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $320.06 to $321.05, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $321.06 to $322.05, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $322.07 to $323.05, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $323.09 to $324.03, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $324.10 to $324.55, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. This option is fully vested. Ryan Metz as Agent for Eric M. Green 2023-03-08